Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
133,168,915
-
Share change
-
+10,561,446
-
Total reported value
-
$634,861,180
-
Put/Call ratio
-
33%
-
Price per share
-
$4.76
-
Number of holders
-
160
-
Value change
-
+$96,615,986
-
Number of buys
-
104
-
Number of sells
-
56
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q2 2020
As of 30 Jun 2020,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,168,915 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Eversept Partners, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), TWO SIGMA INVESTMENTS, LP, and FMR LLC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.